entertainment -WSS

entertainment

author：focus 2025-08-08 05:32:51 - browse：58745

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in a crisp, all-white suit as he strode onto a backlit stage. He was neither. This was Rick Doblin, the founder and evangelist of a movement to legalize psychedelic MDMA and bring the drug into mainstream medicine.

The scene in a Denver conference hall last week was a world away from the first conference Multidisciplinary Association for Psychedelic Studies (MAPS) held in 1990, when Doblin spoke alongside Timothy Leary — the ex-Harvard professor who popularized the phrase “turn on, tune in, and drop out.” That was just a few years after MDMA, also known as ecstasy, was criminalized, deemed a Schedule 1 drug “of no medical use.”

Now, as MAPS nears its goal of winning Food and Drug Administration approval for MDMA as a treatment for post-traumatic stress disorder, the perpetually smiling and energetic Doblin is basking in the adoration from both legions of “psychonauts” and unlikely yet powerful allies. “I literally love Rick Doblin,” the conservative Republican and former Texas governor Rick Perry told the audience in Denver.

It was a seemingly triumphant occasion. But even as Doblin is in sniffing distance of his lifelong quest, his once counter-cultural organization is grappling with the pressures of having to operate in the capitalist pharmaceutical sphere. MAPS was founded in 1986 as a nonprofit with deep-seated ideals. Doblin developed an “anti-patent” strategy, putting discoveries in the public domain so they couldn’t be claimed as intellectual property. He raised money to fund clinical trials of MDMA from like-minded wealthy donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Study: Adult vaccinations pay for themselves in societal benefits

hotspot

WSS

First recipient of genetically engineered pig kidney has died

Feds fine Medicare Advantage plans for overcharging members

Study finds new variant for Parkinson’s in African populations

What do new weight loss drugs mean for bariatric surgery?

Study: Adult vaccinations pay for themselves in societal benefits

After gene therapy, two congenitally deaf children hear for the first time

leisure time

entertainment

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

Winners, losers from Medicare’s list of drugs subject to price talks

The cancer drug shortage isn’t new — and neither are the solutions

Complete sequence of Y chromosome published for first time

New air purifier tech could be key to improving indoor air quality

NYU Langone launches private ChatGPT for its health care data

Tori Bowie and the unacceptable rates of Black maternal death

Readout LOUD podcast: What to know about H5N1 bird flu

In age of alternative facts, a scholarly course on calling out crap

Australia’s approach to dialysis celebrates life

Wikipedia

AstraZeneca bets AAV gene therapy will still deliver the goods

Elevance, private equity launch primary care company

Researchers on aging grapple with how to calculate biological age

Drug firms test therapies to halt Alzheimer’s before symptoms arise

CDC wastewater surveillance dashboard to track bird flu hotspots

Readout LOUD podcast: What to know about H5N1 bird flu

Wikipedia

explore

hotspot

entertainment